Erasca (ERAS) Other Non Operating Income (2023 - 2026)
Erasca (ERAS) posted Other Non Operating Income of $22000.0 for Q1 2026, up 159.46% on a QoQ basis from -$37000.0 in Q3 2025, and up 128.95% year-over-year from $9609.2 in Q1 2025.
Erasca (ERAS) Other Non Operating Income (2023 - 2026) Analysis & Trends
Erasca's Other Non Operating Income history runs 4 years deep, the most recent figure standing at $22000.0 for Q1 2026.
- Quarterly Other Non Operating Income rose 128.95% year-over-year to $22000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $82000.0 (changed N/A YoY) and the FY2022 annual result came in at -$257000.0, down 181.85% from the prior year.
- Other Non Operating Income was $22000.0 for Q1 2026 at Erasca, up from -$37000.0 in the prior quarter.
- Across five years, Other Non Operating Income topped out at $173000.0 in Q3 2024 and bottomed at -$76000.0 in Q1 2025.
- A 4-year average of $6600.0 and a median of -$37000.0 in 2025 frame the typical range for Other Non Operating Income.
- Annual changes were most pronounced in 2024 — Other Non Operating Income jumped 453.06% — and 2025, when it tumbled 121.39%.
- Erasca's Other Non Operating Income stood at -$49000.0 in 2023, then soared by 453.06% to $173000.0 in 2024, then tumbled by 121.39% to -$37000.0 in 2025, then jumped by 159.46% to $22000.0 in 2026.
- Business Quant data shows ERAS's Other Non Operating Income at $22000.0 in Q1 2026, -$37000.0 in Q3 2025, and -$76000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Erasca | 5.89 Bn | 5.89 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 22,000.00 |
| Sep 30, 2025 | -37,000.00 |
| Mar 31, 2025 | -76,000.00 |
| Sep 30, 2024 | 173,000.00 |
| Sep 30, 2023 | -49,000.00 |